Taken together, FGF21 ameliorated the progression of NAFLD by regulating a series of metabolic processes, such as lipid and glucose homeostasis, fatty acid oxidation, oxidation stress and low-grade inflammation. This evidence concerns the gene FGF21 and metabolic dysfunction-associated steatotic liver disease.